Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma

Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma

The identification of cancer stem cells (CSCs), which are implicated in tumor initiation, progression, therapy resistance, and relapse, is of great biological and clinical relevance. In glioblastoma (GBM), this is still a challenge, as no single marker is able to universally identify populations of...

Full description

Bibliographic Details
Main Authors: Joana Vieira de Castro, Céline S. Gonçalves, Eduarda P. Martins, Irene Miranda-Lorenzo, Mariana T. Cerqueira, Adhemar Longatto-Filho, Afonso A. Pinto, Rui L. Reis, Nuno Sousa, Christopher Heeschen, Bruno M. Costa
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
cancer stem cells
glioblastoma stem cells
autofluorescence
biomarker
vitamin B2
Online Access:https://www.mdpi.com/2072-6694/13/4/828

Similar Items

Similar Items